🇺🇸 FDA
Pipeline program

PvCS/Montanide ISA-51 VG Vaccine

2201-3

Phase 2 mab active

Quick answer

PvCS/Montanide ISA-51 VG Vaccine for Plasmodium Vivax Malaria is a Phase 2 program (mab) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Plasmodium Vivax Malaria
Phase
Phase 2
Modality
mab
Status
active

Clinical trials